These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 20411803

  • 21. Autoantibodies in immune-mediated inflammatory neuropathies.
    Martín-Aguilar L, Pascual-Goñi E, Querol L.
    Med Clin (Barc); 2019 Nov 15; 153(9):360-367. PubMed ID: 31443948
    [Abstract] [Full Text] [Related]

  • 22. Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology.
    Franssen H, Straver DC.
    Muscle Nerve; 2014 Jan 15; 49(1):4-20. PubMed ID: 24037667
    [Abstract] [Full Text] [Related]

  • 23. Treatment of dys-immune neuropathies.
    Nobile-Orazio E.
    J Neurol; 2005 Apr 15; 252(4):385-95. PubMed ID: 15834625
    [Abstract] [Full Text] [Related]

  • 24. Paraproteinemia and neuropathy.
    Koike H, Katsuno M.
    Neurol Sci; 2021 Nov 15; 42(11):4489-4501. PubMed ID: 34529193
    [Abstract] [Full Text] [Related]

  • 25. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Csurhes PA, Sullivan AA, Green K, Pender MP, McCombe PA.
    J Neurol Neurosurg Psychiatry; 2005 Oct 15; 76(10):1431-9. PubMed ID: 16170091
    [Abstract] [Full Text] [Related]

  • 26. Immune-Mediated Neuropathies.
    Gwathmey KG, Smith AG.
    Neurol Clin; 2020 Aug 15; 38(3):711-735. PubMed ID: 32703478
    [Abstract] [Full Text] [Related]

  • 27. Immune-mediated neuropathies.
    Kieseier BC, Mathey EK, Sommer C, Hartung HP.
    Nat Rev Dis Primers; 2018 Oct 11; 4(1):31. PubMed ID: 30310069
    [Abstract] [Full Text] [Related]

  • 28. Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies.
    Ruiz M, Puthenparampil M, Campagnolo M, Castellani F, Salvalaggio A, Ruggero S, Toffanin E, Cacciavillani M, Gallo P, Franciotta D, Briani C.
    J Neurol Neurosurg Psychiatry; 2021 Sep 11; 92(9):969-974. PubMed ID: 33850000
    [Abstract] [Full Text] [Related]

  • 29. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH.
    Muscle Nerve; 2009 May 11; 39(5):563-78. PubMed ID: 19301378
    [Abstract] [Full Text] [Related]

  • 30. Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies.
    Briani C, Visentin A.
    Neurotherapeutics; 2022 Apr 11; 19(3):874-884. PubMed ID: 35349079
    [Abstract] [Full Text] [Related]

  • 31. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M, Suzuki S, Takada K, Kusunoki S.
    J Neuroimmunol; 2011 Oct 28; 239(1-2):87-90. PubMed ID: 21914557
    [Abstract] [Full Text] [Related]

  • 32. Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies.
    Magy L, Kaboré R, Mathis S, Lebeau P, Ghorab K, Caudie C, Vallat JM.
    J Immunol Res; 2015 Oct 28; 2015():450391. PubMed ID: 26065001
    [Abstract] [Full Text] [Related]

  • 33. Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.
    Dziadkowiak E, Nowakowska-Kotas M, Rałowska-Gmoch W, Budrewicz S, Koszewicz M.
    Int J Mol Sci; 2023 May 24; 24(11):. PubMed ID: 37298132
    [Abstract] [Full Text] [Related]

  • 34. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M, Nevo Y.
    Eur J Paediatr Neurol; 2009 May 24; 13(3):209-18. PubMed ID: 18585069
    [Abstract] [Full Text] [Related]

  • 35. [Dysimmune neuropathies: current diagnosis and therapy].
    Léger JM, Larue S, Dashi F.
    Rev Prat; 2008 Nov 15; 58(17):1887-9, 1892-4. PubMed ID: 19157204
    [Abstract] [Full Text] [Related]

  • 36. What is new in 2015 in dysimmune neuropathies?
    Kuntzer T.
    Rev Neurol (Paris); 2016 Dec 15; 172(12):779-784. PubMed ID: 27866728
    [Abstract] [Full Text] [Related]

  • 37. Treatment of immune neuropathies.
    Van Doorn PA, Garssen MP.
    Curr Opin Neurol; 2002 Oct 15; 15(5):623-31. PubMed ID: 12352007
    [Abstract] [Full Text] [Related]

  • 38. Immunotherapy in Peripheral Neuropathies.
    Léger JM, Guimarães-Costa R, Muntean C.
    Neurotherapeutics; 2016 Jan 15; 13(1):96-107. PubMed ID: 26602549
    [Abstract] [Full Text] [Related]

  • 39. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy.
    Inglis HR, Csurhes PA, McCombe PA.
    J Neurol Neurosurg Psychiatry; 2007 Apr 15; 78(4):419-22. PubMed ID: 17158557
    [Abstract] [Full Text] [Related]

  • 40. [Diagnosis of immune-mediated neuropathies].
    Diószeghy P.
    Orv Hetil; 2011 Sep 25; 152(39):1560-8. PubMed ID: 21920842
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.